Rutherford Cross retained to appoint part-time Finance Manager by Stirling Anglian Pharmaceutical

Stirling Anglian Pharmaceutical is committed to medicine optimization and is headquartered in Hillington, Glasgow. The business has sourced and developed a portfolio of medicines to help the NHS curb waste across a range of conditions that currently place unnecessary and avoidable pressure on NHS resources. At a time when there is significant pressure on the NHS to reduce costs, the company believes it provides a real and practical solution.

It works closely with stakeholders across the NHS to identify real world problems and develop value-based solutions that support the delivery of efficient and cost-effective healthcare. The company currently owns the distribution licence for 4 distinct pharmaceutical products. At present, the business has a turnover of £10m. The acquisition gives Kelso Pharma an initial UK platform for further acquisitions, product in-licensing and geographic expansion within Europe.

As a result of the acquisition and the ambitious growth plans to develop Stirling Anglian Pharmaceutical into a pan-European specialty healthcare business, the demands on the finance function are increasing. Up until now their finance has been outsourced to a CA firm, but given the growth plans and the requirement for more reliable MI to support decision-making, the finance function will now be brought inhouse.

The Finance Manager position is a part-time role (30 hours per week) and will support the Chief Financial Officer by helping deliver the operational finance needs of the business as well as supporting the processes, data capture and reporting changes necessary to facilitate the coming growth acceleration.

To review a full Position Profile please click here.  For more information please get in touch with Jonathan Donnelly or Harry Young.